Terms: = Colorectal cancer AND BRD4, O60885, 23476, ENSG00000141867, HUNKI, CAP, MCAP AND Clinical Outcome
3 results:
1. Tumor stromal nicotinamide N-methyltransferase overexpression as a prognostic biomarker for poor clinical outcome in early-stage colorectal cancer.
Ogawa M; Tanaka A; Namba K; Shia J; Wang JY; Roehrl MHA
Sci Rep; 2022 Feb; 12(1):2767. PubMed ID: 35177765
[TBL] [Abstract] [Full Text] [Related]
2. clinical Impact of Mismatch Repair Protein Testing on outcome of Early Staged colorectal Carcinomas.
Gandhi JS; Goswami M; Sharma A; Tanwar P; Gupta G; Gupta N; Pasricha S; Mehta A; Singh S; Agarwal M; Gupta N
J Gastrointest Cancer; 2018 Dec; 49(4):406-414. PubMed ID: 28585041
[TBL] [Abstract] [Full Text] [Related]
3. Combined analysis of biomarkers of proliferation and apoptosis in colon cancer: an immunohistochemistry-based study using tissue microarray.
Reimers MS; Zeestraten EC; van Alphen TC; Dekker JW; Putter H; Saadatmand S; Liefers GJ; van de Velde CJ; Kuppen PJ
Int J Colorectal Dis; 2014 Sep; 29(9):1043-52. PubMed ID: 24950792
[TBL] [Abstract] [Full Text] [Related]
